97 related articles for article (PubMed ID: 1923913)
1. The influence of heparin on the prothrombin time.
Schultz NJ; Slaker RA; Rosborough TK
Pharmacotherapy; 1991; 11(4):312-6. PubMed ID: 1923913
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of three dosage-prediction methods for initial in-hospital stabilization of warfarin therapy.
Carter BL; Taylor JW; Becker A
Clin Pharm; 1987 Jan; 6(1):37-45. PubMed ID: 3816105
[TBL] [Abstract][Full Text] [Related]
3. Effect of using warfarin plasma concentrations in Bayesian forecasting of prothrombin-time response.
Lee C; Coleman RW; Mungall DR
Clin Pharm; 1987 May; 6(5):406-12. PubMed ID: 3665392
[TBL] [Abstract][Full Text] [Related]
4. Determination of plasma prothrombin level by Ca2+-dependent prothrombin activator (CA-1) during warfarin anticoagulation.
Iwahashi H; Kimura M; Nakajima K; Yamada D; Morita T
J Heart Valve Dis; 2001 May; 10(3):388-92. PubMed ID: 11380105
[TBL] [Abstract][Full Text] [Related]
5. Warfarin does not interfere with lupus anticoagulant detection by dilute Russell's viper venom time.
Olteanu H; Downes KA; Patel J; Praprotnik D; Sarode R
Clin Lab; 2009; 55(3-4):138-42. PubMed ID: 19462936
[TBL] [Abstract][Full Text] [Related]
6. Excessive prolongation of prothrombin time among patients treated with warfarin and admitted to the emergency room.
Habib G; Nashashibi M; Khateeb A; Goichman S; Kogan A
Eur J Intern Med; 2008 Mar; 19(2):129-34. PubMed ID: 18249309
[TBL] [Abstract][Full Text] [Related]
7. Variations in warfarin concentration in blood and coagulant factors after artificial valve replacement.
Nakamura K; Kariyazono H; Ishibashi M; Shimokawa S; Toyohira H; Taira A
Artery; 1992; 19(6):318-43. PubMed ID: 1471922
[TBL] [Abstract][Full Text] [Related]
8. Safety of intramuscular influenza immunization among patients receiving long-term warfarin anticoagulation therapy.
Raj G; Kumar R; McKinney WP
Arch Intern Med; 1995 Jul; 155(14):1529-31. PubMed ID: 7605155
[TBL] [Abstract][Full Text] [Related]
9. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
[TBL] [Abstract][Full Text] [Related]
10. The management of patients on chronic Coumadin therapy undergoing subsequent surgical procedures.
Madura JA; Rookstool M; Wease G
Am Surg; 1994 Jul; 60(7):542-6; discussion 546-7. PubMed ID: 8010570
[TBL] [Abstract][Full Text] [Related]
11. Low-dose fluconazole therapy potentiates the hypoprothrombinemic response of warfarin sodium.
Crussell-Porter LL; Rindone JP; Ford MA; Jaskar DW
Arch Intern Med; 1993 Jan; 153(1):102-4. PubMed ID: 8422191
[TBL] [Abstract][Full Text] [Related]
12. Single-dose fluconazole for vulvovaginal candidiasis: impact on prothrombin time in women taking warfarin.
Turrentine MA
Obstet Gynecol; 2006 Feb; 107(2 Pt 1):310-3. PubMed ID: 16449117
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulation of juvenile sheep and goats with heparin, warfarin, and clopidogrel.
Connell JM; Khalapyan T; Al-Mondhiry HA; Wilson RP; Rosenberg G; Weiss WJ
ASAIO J; 2007; 53(2):229-37. PubMed ID: 17413565
[TBL] [Abstract][Full Text] [Related]
14. Effect of drug interactions on outcomes of patients receiving warfarin or theophylline.
Jankel CA; McMillan JA; Martin BC
Am J Hosp Pharm; 1994 Mar; 51(5):661-6. PubMed ID: 8203385
[TBL] [Abstract][Full Text] [Related]
15. Changes in plasma warfarin levels and variations in steady-state prothrombin times.
White RH; Zhou H; Romano P; Mungall D
Clin Pharmacol Ther; 1995 Nov; 58(5):588-93. PubMed ID: 7586953
[TBL] [Abstract][Full Text] [Related]
16. The effect of very-low-dose warfarin on markers of hypercoagulation in metastatic breast cancer: results from a randomized trial.
Falanga A; Levine MN; Consonni R; Gritti G; Delaini F; Oldani E; Julian JA; Barbui T
Thromb Haemost; 1998 Jan; 79(1):23-7. PubMed ID: 9459316
[TBL] [Abstract][Full Text] [Related]
17. The incidence, magnitude, and time course of the amiodarone-warfarin interaction.
Kerin NZ; Blevins RD; Goldman L; Faitel K; Rubenfire M
Arch Intern Med; 1988 Aug; 148(8):1779-81. PubMed ID: 3401099
[TBL] [Abstract][Full Text] [Related]
18. [Comparative study of the stability of oral anticoagulant treatments (warfarin vs acenocoumarol)].
Amián A; Rodríguez JN; Muñiz R; Diéguez JC; Moreno MV; Quesada JA; Cañavate M; Fernández-Jurado A; Martino ML; Prados D
Sangre (Barc); 1996 Feb; 41(1):9-11. PubMed ID: 8779047
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib does not significantly alter the pharmacokinetics or hypoprothrombinemic effect of warfarin in healthy subjects.
Karim A; Tolbert D; Piergies A; Hubbard RC; Harper K; Wallemark CB; Slater M; Geis GS
J Clin Pharmacol; 2000 Jun; 40(6):655-63. PubMed ID: 10868317
[TBL] [Abstract][Full Text] [Related]
20. Reduced inhibition of activated prothrombin by heparin and venous thromboembolism: heparin resistance revisited.
Legnani C; Preda L; Palareti G; Lunghi B; Rossi E; Coccheri S
Haematologica; 2002 Feb; 87(2):182-8. PubMed ID: 11836169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
